------------------------------------------------------------------------

Contents (.PDF)       Federal Register

Contents (.TXT)                          Vol. 64, No.42

Thursday, March 4, 1999

------------------------------------------------------------------------

Food and Drug Administration
RULES
ANADA 200-144, CVM98162, Oral Dosage Form New Animal Drugs; Oxytetracycline Hydrochloride Soluble Powder. Page 10389 [FR Doc. 99-5280] [TXT]  [PDF]
NOTICES
Docket No. 98N-0222, OC9955. Agency Information Collection Activities: Proposed
Collection; Comment Request; Dissemination of Information on Unapproved/New Uses for Marketed Drugs, Biologics, and Devices.  Pages 10470-10474 [FR Doc. 99-5387] [TXT]  [PDF]  Written comments by May 3, 1999

Docket No. 98E-0841, OC9953. Determination of Regulatory Review Period for Purposes of Patent Extension; Regranex and Becaplermin Concentrate.  Pages 10474-10475 [FR Doc. 99-5388]  [TXT]  [PDF] Written comments by May 3, 1999 and Petitions by August 31, 1999

OC9954. Advisory Committees; Notice of Meetings.  Pages 10475-10478 [FR Doc. 99-5285] [TXT]  [PDF]